WeRide’s Nasdaq Listing

Skadden advised WeRide Inc., while Latham & Watkins advised the underwriters on the transaction. WeRide was officially listed on the Nasdaq Global Select Market under the...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

QuantaSing’s $40 Million IPO

Wilson Sonsini represented QuantaSing, while Latham & Watkins advised the joint bookrunners on the offering. QuantaSing Group Limited announced the pricing of its initial public offering...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals

Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here